help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hapfelmeier, G.
Right arrow Articles by Rammes, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hapfelmeier, G.
Right arrow Articles by Rammes, G.
Biophysical Journal 84:1720-1733 (2003)
© 2003 The Biophysical Society

Co-expression of the 5-HT3B Serotonin Receptor Subunit Alters the Biophysics of the 5-HT3 Receptor

G. Hapfelmeier*, C. Tredt*, R. Haseneder*, W. Zieglgänsberger{dagger}, B. Eisensamer{dagger}, R. Rupprecht{ddagger} and G. Rammes*,{dagger}

* Department of Anaesthesiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; {dagger} Department of Clinical Pharmacology, Max-Planck-Institute of Psychiatry, Munich, Germany; and {ddagger} Department of Psychiatry, Ludwig-Maximilians-Universität, Munich, Germany

Correspondence: Address reprint requests to Dr. Gerhard Hapfelmeier, Max-Planck-Institute of Psychiatry, Munich Kraepelinstr. 2-10, 80804 Munich, Germany. Tel.: +49-89-30622-255; Fax: +49-89-30622-402; E-mail: hapfelmeier{at}mpipsykl.mpg.de.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Homomeric complexes of 5-HT3A receptor subunits form a ligand-gated ion channel. This assembly does not fully reproduce the biophysical and pharmacological properties of native 5-HT3 receptors which might contain the recently cloned 5-HT3B receptor subunit. In the present study, heteromeric assemblies containing human 5-HT3A and 5-HT3B subunits were expressed in HEK 293 cells to detail the functional diversity of 5-HT3 receptors. We designed patch-clamp experiments with homomeric (5-HT3A) and heteromeric (5-HT3AB) receptors to emphasize the kinetics of channel activation and desensitization. Co-expression of the 5-HT3B receptor subunit reduced the sensitivity for 5-HT (5-HT3A receptor: EC50 3 µM, Hill coefficient 1.8; 5-HT3AB receptor: EC50 25 µM, Hill coefficient 0.9) and markedly altered receptor desensitization. Kinetic modeling suggested that homomeric receptors, but not heteromeric receptors, desensitize via an agonist-induced open-channel block. Furthermore, heteromeric 5-HT3AB receptor assemblies recovered much faster from desensitization than homomeric 5-HT3A receptor assemblies. Unexpectedly, the specific 5-HT3 receptor agonist mCPBG induced an open-channel block at both homomeric and heteromeric receptors. Because receptor desensitization and resensitization massively affect amplitude, duration, and frequency of synaptic signaling, these findings are evidence in favor of a pivotal role of subunit composition of 5-HT3 receptors in serotonergic transmission.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
The 5-HT3 receptor is a ligand-gated ion channel belonging to the Cys-loop superfamily of pentameric proteins (Maricq et al., 1991Go; Yakel, 1992Go). The ion channel is permeable for Na+- and K+- (Yang, 1990Go) and Ca2+- ions (Yang, 1990Go, Hargreaves et al., 1994Go), and probably mediates mainly inward currents and membrane depolarization under physiological conditions (for review: Barnes and Sharp, 1999Go). Activation of postsynaptic 5-HT3 receptors contributes to fast excitatory synaptic transmission in various brain areas, such as the lateral amygdala (Sugita et al., 1992Go) and the visual cortex (Roerig et al., 1997Go), whereas presynaptic 5-HT3 receptors modulate the release of various neurotransmitters, e.g., dopamine (for review, van Hooft and Vijverberg, 2000Go) and GABA (Koyama et al., 2000Go).

Homo-pentameric complexes of recombinant 5-HT3A receptors function efficiently in heterologous expression systems and share some pharmacological and functional properties with native neuronal 5-HT3 receptors (Maricq et al., 1991Go; Boess et al., 1995Go; Green et al., 1995Go). However, there is evidence from more recent studies that some native 5-HT3 receptors, in both humans and rodents, are heteromeric assemblies of 5-HT3A subunits co-expressed with 5-HT3B subunits, which share 41% amino acid identity with the 5-HT3A subunits (Davies et al., 1999Go; Hanna et al., 2000Go). The different recruitment of the 5-HT3B subunit for the formation of heteromeric 5-HT3 receptors might account for some of the heterogeneity of responses after the activation of native 5-HT3 receptors (Yang et al., 1992Go; Hussy et al., 1994Go; Fletcher and Barnes, 1998Go).

The channel closing after activation of an ionotropic receptor channel by an agonist is caused by either agonist unbinding (receptor deactivation) or receptor desensitization (Jones and Westbrook, 1996Go). Desensitization, which defines the entry into an inactive state, even though the agonist remains bound, is a feature shared by most ligand-gated ion channels. It is assumed to be critically involved in the termination of postsynaptic responses, whereas the rate of recovery from desensitization can determine the ability of synapses to respond to repetitive firing (Huganir et al., 1986Go; Huganir and Greengard, 1990Go; Jones and Westbrook, 1996Go). Thus, desensitization could provide an important mechanism for short-term plasticity of synaptic strength. The molecular basis of ion channel desensitization is still poorly understood. Nevertheless, recent studies have started to unravel some of the molecular steps of desensitization of ionotropic glutamate receptors (Sun et al., 2002Go).

Desensitization kinetics of 5-HT3 receptors depend on, e.g., receptor subunit amino acid sequence, extracellular calcium concentration (Gunthorpe et al., 2000Go; Lobitz et al., 2001Go; Yakel, 1996Go; Yakel et al., 1993Go), and the developmental state of cells (Shao et al., 1991Go). The present study investigates the effect of co-expressed 5-HT3B receptor subunits on 5-HT3 receptor activation, desensitization, and recovery from desensitization.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Cell culture
Human embryonic kidney cells (HEK 293, DSMZ, Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany) were maintained in minimum essential medium, supplemented with 10% fetal calf serum, 4 mM L-glutamine, 100 units/ml penicillin, and 100 units/ml streptomycin, in an atmosphere of 5% CO2, 95% air, and 100% relative humidity at 37°C. The cells were harvested two times per week by resuspending in phosphate-buffered saline containing trypsin (100 µg/ml). After washing by centrifugation, and resuspending in fresh medium, the cells were seeded with 20–40% confluency in 20 x 100-mm culture dishes.

Transfection of subunit cDNAs
cDNAs encoding the human 5-HT3A subunit (nucleotides 217–1663, GenBank accession no. D49394) and human 5-HT3B subunit (nucleotides 55–1393, GenBank accession no. AF080582) were cloned into pCDM8 plasmid vectors (Davies et al., 1999Go). Transfection was performed using an electroporation system (Biotechnologies and Experimental Research, San Diego, CA, USA). HEK 293 cells were transfected with plasmids containing cDNA for the human 5-HT3A subunit or cotransfected with cDNAs for the 5-HT3A and 5-HT3B receptor subunits, respectively. A plasmid encoding the cDNA for green fluorescent protein (GFP), as an expression marker, was cotransfected.

After harvesting from a 20 x 100-mm culture dish, the cells were resuspended in a buffer (2 ml) used for transfection (distilled H2O containing—in mM—50 K2HPO4 x 3 H2O, 20 K+-acetate, 25 MgSO4 x 7 H2O, pH 7.35). Plasmids containing cDNAs for the 5-HT3 receptor subunits (3 µg for each subunit) and for GFP (6 µg) were added to the cell suspension. Electroporation was performed at 350 V and 1 mF with a pulse time of 30–45 ms. Transfected cells were replaced in 10 x 35-mm culture dishes with supplemented medium and incubated (5% CO2, 95% air, and 100% relative humidity, 37°C) for 18–24 h before the experiments. After the incubation period, 5–30% of the transfected cells expressed GFP, which is soluble in the cytoplasma, and more than 50% of the green fluorescing cells yielded 5-HT-induced inward currents. The kinetics of 5-HT3 receptor-mediated currents in HEK 293 cells with cotransfected GFP were identical to those in preparations without GFP cDNA cotransfection. As shown by others (Davies et al., 1999Go; Dubin et al., 1999Go), 5-HT (100 µM) did not induce currents in cells transfected with cDNA encoding the 5-HT3B receptor subunit alone.

Electrophysiology
5-HT3 receptor-mediated currents were measured in GFP-positive cells using the whole-cell patch-clamp technique (Hamill et al., 1981Go) at room temperature (20–23°C). After forming the whole-cell configuration, the cells could easily be lifted from the bottom of the culture dish. The agonist-induced currents were recorded under voltage-clamp conditions (-40 mV holding potential, if not otherwise indicated) with an Axopatch 200B patch-clamp amplifier, digitized with a sampling rate of 20 kHz, using a digidata 1200 A/D converter, and low-pass filtered at a cutoff frequency of 2 kHz, performed with pClamp 6.0 software (all from Axon Instruments, Foster City, CA, USA).

For the patch-clamp recordings, the medium was replaced by a solution containing (in mM) 140 NaCl, 2.8 KCl, 10 HEPES, pH 7.2 adjusted with NaOH (extracellular solution). Patch pipettes were pulled from thin-walled borosilicate glass tubes with inner filament (outer diameter 1.5 mm, inner diameter 1.17 mm, GC150TF-10, Clark Electromedical Instruments, Pangbourne, Reading, UK) and heat-polished using a two-step horizontal puller (DMZ-Universal Puller, Zeitz-Instruments, Munich, Germany). The pipettes were coated with Sylgard (Dow Corning, Midland, MI, USA). Series resistance of 4–9 M{Omega} was obtained, when they were filled with a solution containing (in mM) 130 CsCl, 10 EGTA, 10 HEPES, 10 D-glucose, 2 MgCl2, 2 CaCl2, 2 K-ATP, 0.2 Tris GTP, pH 7.2 adjusted with CsOH (intracellular solution). Serial resistance was compensated by >75% by the patch-clamp amplifier. Nonspecific linear leak currents were negligible.

Rapid application and withdrawal of agonists
To mimic the kinetics of synaptic transmitter release, a piezo-driven system for fast exchange of solutions was used (Franke et al., 1987Go). This system (Fig. 1 A) applied the agonist via a liquid filament, i.e., a tiny jet of solution (0.3 ml/min flow rate), discharged from a borosilicate glass tube (inner diameter 150 µm) inside the recording chamber, which was perfused with extracellular solution (2 ml/min). The two solutions form a laminar flow system. The liquid filament consisted of extracellular solution containing indicated concentrations of the respective agonist. The recording chamber and glass tube were connected to a piezo-crystal-driven device (Minitranslator P-249.20, Physik Instrumente, Waldbronn, Germany) that, upon activation, shifted the tube upward by 20 µm to immerse the cell. Upon piezo inactivation, the tube shifted downward to the resting position. The diameter of the HEK 293 cells ranged from 10 to 15 µm, measured by an ocular micrometer. Thus, the cells were clearly smaller than the piezo-driven move. The device allows for a complete exchange of solutions in the vicinity of the cell, held in the whole-cell mode, within 1–5 ms. The time which is required for complete application of the liquid filament (containing the agonist) is, at most, 1.5 ms. This was measured by activation of GABAA receptors by 1 mM GABA ({alpha}1ß2{gamma}2 subunit assembly, expressed in HEK 293 cells, whole-cell configuration; for details, see Hapfelmeier et al., 2001Go). The rise time of the GABA-induced inward current was 1.5 ms (one of 20 representative experiments). The time required for complete withdrawal of the liquid filament is, at most, 4 ms. This was measured by the piezo-driven switch from the liquid filament (GABA solution) to buffer containing the noncompetitive GABAA receptor blocker picrotoxin (Gurley et al., 1995Go). The switch to picrotoxin (1 mM) considerably accelerated the decay of the GABA response, revealing a time constant of 4 ms (one of four representative experiments, Fig. 1 B). The solution exchange might be faster than the measured times, but cannot be slower. The 10–90% rise and decay times of open pipette responses to this exchange of solutions were below 0.1 ms (see also Heckmann et al., 1996Go).



View larger version (36K):
[in this window]
[in a new window]
 
FIGURE 1  (A) The "fast-switch" system. To mimic the kinetics of synaptic release, a system for rapid exchange of solutions was used. The "liquid filament" consists of extracellular solution containing the agonist. Upon piezo-crystal activation, it shifts upward by 20 µm and the whole-cell patch carrying the 5-HT3 receptors is immersed. Upon piezo inactivation, the liquid filament shifts downward to the resting position. This device allows for a complete exchange of solutions in the vicinity of the cell within 1–5 ms. (B) The time required for complete application of the liquid filament is, at most, 1.5 ms: activation of GABAA receptors by 1 mM GABA reveals a rise time of the GABA-induced current of 1.5 ms (left). The time required for withdrawal of the liquid filament is, at most, 4 ms: the piezo-driven switch from the liquid filament (GABA solution) to buffer containing the noncompetitive GABAA receptor blocker picrotoxin (1 mM) considerably accelerates the decay of the GABA response, revealing a time constant of 4 ms (mid). When GABA and picrotoxin are co-applied, the GABA response is rapidly reduced. On rapid withdrawal of the liquid filament, the unblocking of picrotoxin evokes a tail current (right).

 
Sources of chemicals
5-HT was purchased from Sigma Chemicals (Deisenhofen, Germany), the selective 5-HT3 receptor agonist m-chlorophenylbiguanide (mCPBG) (Kilpatrick et al., 1990Go) and the selective 5-HT3 receptor antagonist [n-(1-azabicyclo[2.2.2]oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-1,4 benzo-xazine-8-carboxamide hydrochloride] (Y25130) (Sato et al., 1992Go) from TOCRIS (Bristol, UK). The compounds were dissolved in extracellular solution.

Data analysis
Peak current and time to peak (10–90% rise time) were measured using automated detection algorithms (AxoGraph software for MacOS). Receptor desensitization was measured as the decay of the agonist-evoked response in the continued presence of agonist. Receptor deactivation was measured as the decay of the response after the rapid withdrawal of the agonist. The decaying phases of the currents were fitted with AxoGraph software. Biexponential fitting was performed when the monoexponential fit was apparently inadequate. EC50 and Hill coefficient were calculated with SigmaPlot 5.00. Data are presented as mean ± SD with the number of experiments indicated.

Computer simulations
Simulations of kinetic schemes and sets of rate constants were performed with a program for macroscopic current modeling (BIOQ-Biochemical Equations software) kindly provided by Prof. Hanna Parnas (Parnas and Parnas Neurobiology Lab, Hebrew University, Jerusalem, Israel). This software, for solving a set of differential equations, is a Windows-compatible update based on a UNIX-compatible program for an analytic description of synaptic currents (http://www.ls.huji.ac.il/~parnas/Bioq/bioq.html).

Our experiments were designed to emphasize the 5-HT3 receptor kinetics of activation, desensitization, and deactivation. The agonist-evoked responses were simulated with kinetic schemes, which are based on the three-state-kinetic-model theory first put forward by del Castillo and Katz (1957)Go. The configuration of the kinetic scheme and the set of rate constants were designed to match simulated and measured responses under the varied experimental conditions.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
It has previously been shown that homomeric 5-HT3A and heteromeric 5-HT3AB receptors expressed in HEK 293 cells are equally permeable for Na+ and K+, but that 5-HT3AB receptors are less permeable for Ca2+ than 5-HT3A receptors (Davies et al., 1999Go). It is commonly accepted that an increase in extracellular calcium and/or magnesium decreases the current response and accelerates the desensitization of 5-HT3 receptors (Brown et al., 1998Go; Maricq et al., 1991Go; Mochizuki et al., 1999Go; Yakel, 1992Go). The accelerating effect of calcium ions on the desensitization of human homomeric 5-HT3A receptors has been reported recently (Lobitz et al., 2001Go). To eliminate 1), the influence of extracellular calcium and magnesium ions on desensitization and 2), the differences in calcium permeability of homomeric and heteromeric 5-HT3 receptors, we performed our experiments in calcium- and magnesium-free extracellular solutions, as in previous studies with heterologously expressed 5-HT3 receptors (Lankiewicz et al., 1998Go; Lobitz et al., 2001Go).

Kinetics of 5-HT3A and 5-HT3AB receptors activated by 5-HT
To obtain a kinetic model which simulates the agonist-induced whole-cell currents resulting from the respective application protocol, we designed reaction schemes with sets of rate constants compatible with the present results. The constraints for the chosen rate constants were given by the experimental data, e.g., dose-response curves, time constants of activation, desensitization, and deactivation (see Table 1). Consequently, the kinetic model results in matching the data obtained from the sets of experiments described below.


View this table:
[in this window]
[in a new window]
 
TABLE 1  Parameters and rate constants with source of their experimental constraints

 


View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 3  Dose-response relationship for 5-HT3A receptor activation by 5-HT. (A) Whole-cell currents, induced by stepwise increased concentrations of 5-HT. (B) Pooled data of the dose-response relationship for the current amplitude (top) and the 10–90% rise time (bottom). The measured data (open squares, number of experiments in brackets, mean ± SD) are mimicked by the simulated data (filled triangles). For receptor activation, the EC50 of 5-HT was 3 ± 0.6 µM. The Hill coefficient of 1.8 ± 0.3 suggests two agonist binding steps required for channel gating. (C) Corresponding simulated currents generated by the 5-HT3A receptor model (see Fig. 2 B) with imposed agonist concentrations. (A, inset) The responses recorded from outside-out patches also involved tail currents. Due to fluctuations, these tail currents were, in part, less prominent compared to the whole-cell responses. (C, inset) The single-channel simulations performed with the same kinetic model covered this finding. The simulated responses of 1000 channels were very similar to the outside-out currents.

 


View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 2  (A) 5-HT3A receptor response. Application (for 1.5 s, gray bar) of 5-HT (10 µM) to a HEK 293 cell carrying 5-HT3A receptors induced an inward current that desensitized, revealing two time constants. The rapid withdrawal of 5-HT (dashed line) induced a tail current (inset). (B) The kinetic model for the 5-HT3A receptor embodies closed C, open O, and blocked B states of the receptor channel. Both the biphasic desensitization and the slow-deactivating tail current were best simulated by a model embodying a high-affinity and a low-affinity open-channel-block state Bh and Bl. (C) The simulated current is a plot of the probability of the open state O over time. (D) A representative 5-HT3AB receptor current, induced by 5-HT (30 µM), desensitized with only one time constant. On the withdrawal of 5-HT, no tail current was induced, and the current rapidly deactivated with a time constant of 105 ms (inset). (E) The kinetic model for the 5-HT3AB receptor, which best reconciles the experimental data, embodies one agonist binding step and classical receptor desensitization. (F) The simulated current matches the measured current.

 


View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 5  Kinetics of 5-HT3A receptor resensitization. Repetitive pulses (gray bars) of 5-HT (10 µM) were applied. (A) Current traces from a representative cell. (B) Simulated currents (model provided in Fig. 2 B). Recovery of the response to >50% (>95%) required 7 s (25 s, mean ± SD, n = 3). An interval of 0.5 s between the two agonist pulses resulted in an overlap of the second pulse and the tail current (A, top, inset) resulting in a current decay within the tail current. This effect, which is reconciled with an agonist-induced open-channel block, was also predicted by the model (B, top).

 


View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 4  Dose-response relationship for 5-HT3AB receptor activation by 5-HT. (A) Whole-cell currents, induced by different concentrations of 5-HT. (B) Pooled data of the dose-response relationship for the current amplitude (top), the 10–90% rise time (middle), and the time constant of current deactivation (bottom). The measured data (open squares, number of experiments in brackets, mean ± SD) are matched by the simulated data (filled triangles). For receptor activation, the EC50 of 5-HT was 25 ± 4 µM. The Hill coefficient of 0.9 ± 0.1 suggests that only one agonist binding step is required for channel gating. (C) Corresponding simulated currents generated by the 5-HT3AB receptor model (see Fig. 2 E).

 


View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 7  (A) 5-HT3A receptor whole-cell currents, evoked by 5-HT (10 µM) pulses of different duration (one representative of three cells). On the 5-HT pulse of 20 ms, the response was reduced and no tail current occurred (bottom trace). (B) Simulated currents. (C) 5-HT3AB receptor whole-cell currents, evoked by 5-HT pulses of different duration (one representative of five cells). Shortening the 5-HT pulse reduced the time constant of receptor deactivation (insets). (D) Simulated currents.

 


View larger version (15K):
[in this window]
[in a new window]
 
FIGURE 6  Kinetics of 5-HT3AB receptor resensitization. Repetitive pulses (gray bars) of 5-HT (100 µM) were applied. (A) Current traces from a representative cell. (B) Simulated currents (5-HT3AB receptor model, see Fig. 2 E). Recovery of the response to >50% (>95%) required 3 s (12 s, mean ± SD, n = 5). After shorter intervals between the agonist pulses, a small current with kinetics similar to those of the initial response was induced by the second pulse (see also inset). This effect is reconciled with classical receptor desensitization and was also predicted by the model.

 
The agonist was applied via the fast-switch system (Fig. 1 A) to cells carrying 5-HT3A or 5-HT3AB receptors. Fig. 2 A shows an inward current through 5-HT3A receptor channels evoked by 5-HT (10 µM). After reaching a peak, the current decayed in the presence of 5-HT, revealing two time constants. Conspicuously, the rapid withdrawal of 5-HT induced a transient increase in the current (inset). Such tail currents are typical for the offset of an open-channel block. Pursuant to this, the possible kinetic scheme that best simulated both the biphasic decay of the current (desensitization), and the slow-deactivating tail current, embodies a high-affinity and a low-affinity open-channel block by the agonist as the relevant mechanism of 5-HT3A receptor desensitization (Fig. 2, B and C).

Fig. 2 D depicts a representative whole-cell current evoked by 5-HT (30 µM) via activation of heteromeric 5-HT3AB receptors. In contrast to homomeric 5-HT3A receptors, the 5-HT3AB receptor current desensitized with only one time constant, and the rapid withdrawal of 5-HT from the 5-HT3AB receptors did not induce any tail current. The current rather deactivated rapidly on discontinuation of 5-HT (inset). The possible kinetic scheme that reconciles these findings most suitably embodies classical receptor desensitization; i.e., isomerization from an active to an inactive state not requiring any additional binding steps (Fig. 2 E). Fig. 2 F depicts a simulated 5-HT3AB receptor current that was generated using the provided model (Fig. 2 E) with the respective concentration of 5-HT imposed.

Dose-response relationship for receptor activation by 5-HT
Fig. 3 A shows 5-HT3A receptor whole-cell currents evoked by stepwise increased 5-HT concentrations. The dose-response relationship for amplitude (EC50 3 ± 0.6 µM; Hill 1.8 ± 0.3) and kinetics (10–90% rise time, desensitization, and time course of tail currents) of the currents was best simulated (Fig. 3, B and C) by the 5-HT3A receptor model provided in Fig. 2 B. A mismatch between experiment and simulation was only seen in desensitization kinetics of the current induced by 30 µM 5-HT (see Fig. 3, A and C, bottom). The model also predicted that channel gating requires two agonist binding steps to obtain a (simulated) Hill coefficient of 1.8. A corresponding model without binding steps for channel block (no receptor desensitization; data not shown) yielded a Hill coefficient of 1.95.

The responses evoked by 10 µM 5-HT applied to out-side-out patches carrying homomeric 5-HT3A receptors also showed tail currents (Fig. 3 A, inset). Due to fluctuations, these tail currents were, in part, less prominent compared to the whole-cell responses. Nevertheless, single-channel simulations performed with the same kinetic model and the same set of rate constants (see Fig. 2 B) covered this finding. The simulated responses of 1000 channels (Fig. 3 C, inset) also involved fluctuations and were very similar to the outside-out currents.

Fig. 4 A depicts whole-cell currents evoked by 5-HT via activation of heteromeric 5-HT3AB receptors. Here, no tail currents were induced by the withdrawal of 5-HT (tested up to 100 mM; data are shown up to 1 mM). These currents (EC50 25 ± 4 µM; Hill 0.9 ± 0.1) were best simulated (Fig. 4, B and C) by the 5-HT3AB receptor model (provided in Fig. 2 E) which requires, in contrast to the 5-HT3A receptor model (see Fig. 2 B), only one agonist binding step for channel gating. This 5-HT3AB receptor model also predicted the experimental finding that the time constant of receptor deactivation will moderately increase with increasing agonist concentrations (Fig. 4 B, bottom).

Kinetics of recovery from receptor desensitization
Repetitive pulses of 5-HT (10 µM) were used to monitor the time course of receptor resensitization (Figs. 5 and 6). Recovery of the 5-HT3A receptor response to >50% and >95% required 7 s and 25 s, respectively (Fig. 5 A), closely matching the simulated currents (Fig. 5 B). When the repetitive 5-HT application to 5-HT3A receptors coincided with the tail current (re-opened channels), conspicuously, the tail current decayed with a time course similar to the decay of the initial response (Fig. 5 A, top trace, inset). This feature of the current was also predicted by the model (Fig. 5 B, top) and is well reconciled with the 5-HT-induced channel block. Kinetic schemes that do not embody such an agonist-induced block could not simulate this response (not shown). Within the given model, the rate constant Koffbh (0.2 s-1) defines the 95%-recovery time of 25 s. Fig. 5 B (bottom) additionally depicts the simulated time course of recovery of the resting state C of the receptor.

The recovery of the 5-HT3AB receptor response to >50% (>95%) required 3 s (12 s) (Fig. 6 A). Obviously, heteromeric 5-HT3AB receptors resensitized substantially faster than homomeric 5-HT3A receptors, a finding well-predicted by the 5-HT3AB receptor model (Fig. 6 B).

Decrease in agonist application time
In the experiments with homomeric 5-HT3A receptors, a stepwise decrease in application time diminished the resulting tail current and accelerated the deactivation phase of the currents (Fig. 7, A and B). The model also predicted that the current induced by exposure to 5-HT for only 20 ms decayed without any preceding tail current (Fig. 7, A and B, bottom). Under these conditions, the closing of the 5-HT3A receptor channels might occur, due to receptor deactivation, before 5-HT could block the opened channels (open-channel block). The 5-HT3A receptor response decreased in amplitude (Fig. 7, A and B, bottom), because the application time (20 ms) was shorter than the time required to reach the peak current (10–90% rise time: 38 ± 13 ms with 10 µM 5-HT).

In the experiments with heteromeric 5-HT3AB receptors, a stepwise decrease in application time from 1500 ms to 100 ms decreased the fraction of current decay due to desensitization and increased the fraction due to deactivation (Fig. 7, C and D). In line with our 5-HT3AB receptor model, the time constant of deactivation became shorter when the application time was decreased (Fig. 7, C and D). In agreement with others (Jones and Westbrook, 1995Go), this model predicts that receptors in a desensitized state can prolong agonist-induced responses. Obviously, this mechanism is even more effective when desensitization results from an agonist-induced channel block (see Fig. 7, A and B).

Current-voltage relationship for receptor activation by 5-HT
The I-V curve of 5-HT3A receptor responses showed a slight inward rectification (Fig. 8 A). However, the holding potential did not influence the kinetics of the 5-HT-induced currents. The induction of the tail currents was voltage-independent suggesting that 5-HT induced a voltage-independent open-channel block at the homomeric 5-HT3A receptors. The selective 5-HT3 receptor antagonist Y25130 (10 nM) reduced the 5-HT3A receptor currents (Fig. 8, B). A complete block of the currents was achieved by 300 nM Y25130 (not shown).



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 8  (A) The current-voltage plot of 5-HT3A receptor currents induced by 5-HT reveals slight inward rectification (mean ± SD, n = 3). The inset shows a series of currents recorded at holding potentials from -90 to +70 mV. The induction of tail currents was voltage-independent. (B) The selective 5-HT3 receptor antagonist Y25130 (10 nM) reduced the 5-HT3A receptor-mediated current. (C) The current-voltage plot of 5-HT3AB receptor currents induced by 5-HT also reveals slight inward rectification (mean ± SD, n = 3). The inset shows a series of currents, recorded from a representative cell at holding potentials from -90 to +50 mV. The kinetics of the 5-HT3AB receptor currents were voltage-independent. (D) The selective 5-HT3 receptor antagonist Y25130 (10 nM) reduced the 5-HT3AB receptor-mediated current.

 
The I-V curve determined for the heteromeric 5-HT3AB receptors (Fig. 8 C) also showed a slight inward rectification (seen at >30 mV). As in homomeric 5-HT3A receptors, the kinetics of these currents were voltage-independent and the responses were reduced by Y25130 (10 nM) (Fig. 8 D).

Receptor activation by the specific 5-HT3 receptor agonist mCPBG
Activation of homomeric 5-HT3A receptors by increasing concentrations of the agonist mCPBG resulted in a bell-shaped dose-response curve. The withdrawal of mCPBG (>3 µM) evoked a prominent tail current (Fig. 9 A). Receptor resensitization to repetitive mCPBG pulses was rather slow. The recovery of the response to >50% (>95%) required 20 s (50 s) (Fig. 9 B).



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 9  (A) The application (gray bar) of the selective 5-HT3 agonist mCPBG to cells carrying homomeric 5-HT3A receptors evoked inward currents. The dose-response curve for mCPBG-induced receptor activation is bell-shaped (mean ± SD, number of experiments in brackets, bottom). The withdrawal of mCPBG (10 µM, 30 µM) induced prominent tail currents. (B) Repetitive pulses of mCPBG (10 µM) were used to monitor the time course of receptor resensitization. The data are given as mean ± SD (n = 3).

 
Also the heteromeric 5-HT3AB receptors were sensitive to mCPBG (Fig. 10 A). In contrast to 5-HT, a tail current was evoked by high concentrations of mCPBG (100 µM) (Fig. 10 A, bottom). This finding suggests that mCPBG can induce an open-channel block also at 5-HT3AB receptors. The induction of the tail currents was voltage-independent and occurred without rectification (Fig. 10 B).



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 10  Application of mCPBG to cells carrying heteromeric 5-HT3AB receptors. (A) 5-HT (100 µM) induced an inward current without tail current (top). mCPBG also induced inward currents. In contrast to 5-HT, the withdrawal of mCPBG (100 µM) induced a tail current (bottom). (B) The mCPBG-induced responses did not show any rectification.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
We compared the different activation and inactivation kinetics of homomeric and heteromeric human 5-HT3 receptors expressed in HEK 293 cells. The time constants of 5-HT3 receptor activation and desensitization and the EC50 and Hill values obtained resemble those published previously (for review, see Reeves and Lummis, 2002Go). The differences between native and heterologously expressed homomeric 5-HT3 receptors were attributed to a factor associated to native receptors (Hooft et al., 1997Go) until the 5-HT3B receptor subunit was identified and cloned (Davies et al., 1999Go).

5-HT3A receptor desensitization
Based on the main finding that rapid withdrawal of 5-HT from 5-HT3A receptors evoked tail currents, we designed a model for receptor desensitization due to an agonist-induced open-channel block. We attributed the double-exponential time course of desensitization to the overlapping of a low-affinity and a high-affinity block (see Fig. 2, AC).

The 5-HT3A receptor currents depicted in various recent papers (Lankiewicz et al., 1998Go; Brown et al., 1998Go; Davies et al., 1999Go; Dubin et al., 1999Go, Gunthorpe and Lummis, 2001Go) most commonly do not display tail currents on agonist discontinuation. Instead, a rather slow receptor deactivation is typically seen in these recordings. The most parsimonious explanation for this finding is that the slow withdrawal of the agonist by the devices employed for application suppresses the induction of a perspicuous tail current. Mott et al. (2001)Go employed a rapid switching system to apply agonists to murine homomeric 5-HT3A receptors. The authors observed deactivation kinetics similar to or slower than desensitization, which is also in line with our findings. In this study tail currents are not reported, but it is conspicuous to us that the time course of whole-cell currents after a prolonged agonist application is not depicted in detail. The authors provide a rather complex model for receptor desensitization to match their data. Our aim was to suggest a simplified model including a self-block by the agonist to match the characteristic time course of the responses of human homomeric 5-HT3A receptors.

The fast-switch system (Fig. 1 A) employed in the present study allows the discernment of tail currents as a kinetic property of ligand-gated ion channels featuring the offset of an open-channel block (Hapfelmeier et al., 2001Go). 5-HT3A receptor-associated tail currents have apparently been recorded, but have not been detailed any further (Lankiewicz et al., 1998Go; Dubin et al., 1999Go). These findings also involved ion-selectivity-converted 5-HT3A receptors (Gunthorpe and Lummis, 2001Go). In a previous study, Gunthorpe and Lummis (1999)Go attributed the reappearance of the inward current (which we termed tail current) through murine 5-HT3A receptors to the offset of an open-channel block by diltiazem, and provided a simple scheme for this mechanism. High concentrations of 5-hydroxyindole also block 5-HT3 receptors and induce tail currents on washout, whereas low concentrations potentiate the 5-HT-induced currents (Kooyman et al., 1994Go). These findings are in line with our present data which suggest two distinct binding sites for 5-HT, which convey opposite effects on the 5-HT3A receptor. A binding site in the channel pore (involved in open-channel block) is suggested by the finding that mutations in putative channel lining domains of cloned 5-HT3 receptors strongly determined the time course of desensitization, especially under calcium-free conditions (Yakel et al., 1993Go; Gunthorpe et al., 2000Go; Lobitz et al., 2001Go).

5-HT3AB receptor desensitization
The desensitization phase of 5-HT3AB receptor currents was not followed by a tail current, even at rather high 5-HT concentrations, excluding a channel block as the underlying mechanism for receptor desensitization. We used a reaction scheme based on classical receptor desensitization, a mechanism first put forward by Katz and Thesleff (1957)Go, and emphasized also in recent studies (Jones and Westbrook, 1996Go; Sun et al., 2002Go). Our cyclic scheme is based on the finding that the rate d-1 has to be 0.1 s-1 or less to cover the kinetics of receptor desensitization. However, in a linear model, this value of d-1 would not allow for recovery from desensitization within ~12 s, as was found in the experiments. Under these conditions, (simulated) resensitization would require more than 60 s. To account for faster resensitization, we must consider a cyclic model which provides an alternate, faster return path to the resting state (C) of the receptor. In this cyclic scheme, the rate constant d-2 (0.25 s-1) then results in the desired recovery time of 12 s. The value of the rate constant d+2 can hardly be determined by experiments, because this rate represents the desensitization of "sleeping channels". The fraction of desensitized to active receptors in the absence of the agonist (d+2/d-2) was suggested to be on the order of 0.1 or less (Dilger and Liu, 1992Go). We set the value of d+2 to 0.01 s-1, because if d+2 considerably exceeds this value, the kinetics of resensitization (see Fig. 6) cannot be simulated well. The provided kinetic model (see Fig. 2 E) simulated the activation, desensitization, deactivation, and resensitization of the 5-HT3AB receptor-mediated currents.

Our model also predicted that desensitized states can prolong receptor responses by slowing receptor deactivation (Jones and Westbrook, 1995Go; 1996Go). This effect would preferentially affect synaptic transmission at serotonergic synapses carrying homomeric 5-HT3A receptors, which might desensitize due to an open-channel block and, thus, deactivate rather slowly (see Fig. 7 A). Recently, an enhancement of neuromuscular transmission in zebrafish has been attributed to an agonist-induced, open-channel block of acetylcholine receptors (Legendre et al., 2000Go).

The effect of mCPBG on 5-HT3 receptors
Like 5-HT, the 5-HT3 agonist mCPBG induced a concomitant open-channel block at homomeric 5-HT3A receptors. The self-block by mCPBG even resulted in a bell-shaped dose-response curve for current amplitude. Furthermore, receptor resensitization under mCPBG was clearly slower than under the natural ligand, an effect which has been also reported for native mouse 5-HT3 receptors (van Hooft and Vijverberg, 1996Go).

In the present study, mCPBG also acted as a potent agonist at the heteromeric 5-HT3AB receptors. Unexpectedly, mCPBG, but not 5-HT, also evoked tail currents at the 5-HT3AB receptors (see Fig. 10), suggesting that, in contrast to 5-HT, mCPBG can induce an open-channel block at these receptors. We conclude that the mechanisms of desensitization depend on both receptor subunit composition and ligand properties.

Does kinetic modeling help to unravel 5-HT3 receptor-mediated signaling?
The sigmoid time course of the initial part of resensitization of homomeric 5-HT3A receptors (see Fig. 5), which resembles that reported for murine 5-HT3 receptors (van Hooft and Vijverberg 1996Go), is an experimental finding not predicted by our kinetic model. A multistep mechanism for resensitization, suggested by van Hooft and Vijverberg (1996)Go, or the introduction of dynamic rates instead of rate constants, would match these experimental data. Interestingly, Mott et al. (2001)Go report simple-exponential time course of murine 5-HT3A receptor resensitization, which would be in line with our 5-HT3A receptor model.

Some of our recordings showed double-exponential time course of receptor deactivation after brief agonist pulses. This was also seen by Mott et al. (2001)Go. However, we surrendered to expand our model to match these findings in detail, because our aim was to provide simplified models to focus on the different properties of homomeric and heteromeric 5-HT3 receptors.

Data from various ligand-gated ion channels provide evidence for strikingly different patterns by which receptor-specific kinetics of desensitization can determine the size, time course, and frequency of synaptic transmission (for review, see Jones and Westbrook, 1996Go). The present study shows that homomeric and heteromeric 5-HT3 receptors substantially differ in the mechanisms underlying desensitization, sensitivity for the endogenous agonist, and time required for resensitization. These findings might help to unravel the complexity of serotonergic synaptic transmission. Furthermore, our findings address the problem that the homopentameric 5-HT3 receptor assemblies do not fully reproduce the biophysical characteristics of some native receptors (for review, see Fletcher and Barnes, 1998Go). In line with others (Mott et al., 2001Go), we found that, in homomeric receptors, the kinetics of deactivation are slower or similarly slow compared to the desensitization phase. In heteromeric receptors, the kinetics of deactivation are significantly faster than those of desensitization, a finding which is typically seen in native 5-HT3 receptors (Zhou and Galligan, 1999Go). It also remains to be shown if the agonist-induced channel block could be relevant for the very small single-channel conductance values obtained in homopentameric receptors (for review, see Fletcher and Barnes, 1998Go). In heteromeric and native receptors, distinct single-channel events with relatively high conductances were recorded (Davies et al., 1999Go; Zhou and Galligan, 1999Go). Nevertheless, neither the homomeric nor the heteromeric assembly can be considered as the "more nativelike" receptor, since recent findings suggest the differential expression of both homomeric and heteromeric 5-HT3 receptors in sensory neurons (Morales et al., 2001Go).


    ACKNOWLEDGEMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
We thank Ewen F. Kirkness for providing the cDNAs; Prof. Hanna Parnas, Prof. Itzhak Parnas, and Eli Ratner (Hebrew University, Jerusalem, Israel) for providing BIOQ software; Sebastian Schmidt for expert technical assistance; and Dr. Helmuth Adelsberger for his help with kinetic modeling.

Submitted on August 6, 2002; accepted for publication November 22, 2002.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Barnes, N. M., and T. Sharp. 1999. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1083–1152.[Medline]

Boess, F. G., R. Beroukhim, and I. L. Martin. 1995. Ultrastructure of the 5-hydroxytryptamine3 receptor. J. Neurochem. 64:1401–1405.[Medline]

Brown, A. M., A. G. Hope, J. J. Lambert, and J. A. Peters. 1998. Ion permeation and conduction in a human recombinant 5-HT3 receptor subunit (h5-HT3A). J. Physiol. 507:653–665.[Abstract/Free Full Text]

Davies, P. A., M. Pistis, M. C. Hanna, J. A. Peters, J. J. Lambert, T. G. Hales, and E. F. Kirkness. 1999. The 5-HT3B subunit is a major determinant of serotonin receptor function. Nature. 397:359–363.[Medline]

del Castillo, J., and B. Katz. 1957. Interaction at endplate receptors between different choline derivatives. Proc. R. Soc. Lond. B Biol. Sci. 146:369–381.[Medline]

Dilger, J. P., and Y. Liu. 1992. Desensitization of acetylcholine receptors in BC3H–1 cells. Pflugers Arch. 420:479–485.[Medline]

Dubin, A. E., R. Huvar, M. R. D'Andrea, J. Pyati, J. Y. Zhu, K. C. Joy, S. J. Wilson, J. E. Galindo, C. A. Glass, L. Luo, M. R. Jackson, T. W. Lovenberg, and M. G. Erlander. 1999. The pharmacological and functional characteristics of the serotonin 5-HT3A receptor are specifically modified by a 5-HT3B receptor subunit. J. Biol. Chem. 274:30799–30810.[Abstract/Free Full Text]

Fletcher, S., and N. M. Barnes. 1998. Desperately seeking subunits: are native 5-HT3 receptors really homomeric complexes? Trends Pharmacol. Sci. 19:212–215.[Medline]

Franke, C., H. Hatt, and J. Dudel. 1987. Liquid filament switch for ultra-fast exchanges of solutions at excised patches of synaptic membrane of crayfish muscle. Neurosci. Lett. 77:199–204.[Medline]

Green, T., K. A. Stauffer, and S. C. R. Lummis. 1995. Expression of recombinant homo-oligomeric 5-hydroxytryptamine3 receptors provides new insights into their maturation and structure. J. Biol. Chem. 270:6056–6061.[Abstract/Free Full Text]

Gunthorpe, M. J., and S. C. R. Lummis. 1999. Diltiazem causes open channel block of recombinant 5-HT3 receptors. J. Physiol. 519:713–722.[Abstract/Free Full Text]

Gunthorpe, M. J., and S. C. R. Lummis. 2001. Conversion of the ion selectivity of the 5-HT3A receptor from cationic to anionic reveals a conserved feature of the ligand-gated ion channel superfamily. J. Biol. Chem. 276:10977–10983.[Abstract/Free Full Text]

Gunthorpe, M. J., J. A. Peters, C. H. Gill, J. J. Lambert, and S. C. R. Lummis. 2000. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors. J. Physiol. 522:187–198.[Abstract/Free Full Text]

Gurley, D., J. Amin, P. C. Ross, D. S. Weiss, and G. White. 1995. Point mutations in the M2 region of the {alpha}, ß, or {gamma} subunit of the GABAA channels that abolish block by picrotoxin. Receptors Channels. 3:13–20.[Medline]

Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. Sigworth. 1981. Improved patch-clamp techniques for high resolution current recordings from cells and cell-free membrane patches. Pflugers Arch. 391:85–100.[Medline]

Hanna, M. C., P. A. Davies, T. G. Hales, and E. F. Kirkness. 2000. Evidence for expression of heteromeric serotonin 5-HT3 receptors in rodents. J. Neurochem. 75:240–247.[Medline]

Hapfelmeier, G., R. Haseneder, E. Kochs, M. Beyerle, and W. Zieglgänsberger. 2001. Coadministered nitrous oxide enhances the effect of isoflurane on GABAergic transmission by an increase in open-channel block. J. Pharmacol. Exp. Ther. 298:201–208.[Abstract/Free Full Text]

Hargreaves, A. C., S. C. R. Lummis, and C. W. Taylor. 1994. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors. Mol. Pharmacol. 46:1120–1128.[Abstract]

Heckmann, M., J. Bufler, C. Franke, and J. Dudel. 1996. Kinetics of homomeric GluR6 glutamate receptor channels. Biophys. J. 71:1743–1750.[Abstract/Free Full Text]

Huganir, R. L., A. H. Delcour, P. Greengard, and G. P. Hess. 1986. Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization. Nature. 321:774–776.[Medline]

Huganir, R. L., and P. Greengard. 1990. Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron. 5:555–567.[Medline]

Hussy, N., W. Lukas, and K. A. Jones. 1994. Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. J. Physiol. 481:311–323.[Medline]

Jones, M. V., and G. L. Westbrook. 1995. Desensitized states prolong GABAA channel responses to brief agonist applications. Neuron. 15:181–191.[Medline]

Jones, M. V., and G. L. Westbrook. 1996. The impact of receptor desensitization on the fast synaptic transmission. Trends Neurosci. 19:96–101.[Medline]

Katz, B., and S. Thesleff. 1957. A study of ‘desensitization’ produced by acetylcholine at the motor end-plate. J. Physiol. (Lond.). 138:63–80.[Free Full Text]

Kilpatrick, G. J., A. Butler, J. Burridge, and A. W. Oxford. 1990. 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist. Eur. J. Pharmacol. 182:193–197.[Medline]

Kooyman, A. R., J. A. van Hooft, P. M. Vanderheijden, and H. P. Vijverberg. 1994. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E–115 neuroblastoma cells. Br. J. Pharmacol. 112:541–546.[Medline]

Koyama, S., N. Matsumoto, C. Kubo, and N. Akaike. 2000. Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons. J. Physiol. 529:373–383.[Abstract/Free Full Text]

Lankiewicz, S., N. Lobitz, C. H. Wetzel, R. Rupprecht, G. Gisselmann, and H. Hatt. 1998. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig. Mol. Pharmacol. 53:202–212.[Abstract/Free Full Text]

Legendre, P., D. W. Ali, and P. Drapeau. 2000. Recovery from open channel block by acetylcholine during neuromuscular transmission in zebrafish. J. Neurosci. 20:140–148.[Abstract/Free Full Text]

Lobitz, N., G. Gisselmann, H. Hatt, and C. H. Wetzel. 2001. A single amino-acid in the TM1 domain is an important determinant of the desensitization kinetic of recombinant human and guinea pig alpha-homomeric 5-hydroxytryptamine type 3 receptors. Mol. Pharmacol. 59:844–851.[Abstract/Free Full Text]

Maricq, A. V., A. S. Peterson, A. J. Brake, R. M. Myers, and D. Julius. 1991. Primary structure and functional expression of the 5-HT3 receptor, a serotonin-gated ion channel. Science. 254:432–437.[Abstract/Free Full Text]

Mochizuki, S., A. Miyake, and K. Furuichi. 1999. Ion permeation properties of a cloned human 5-HT3 receptor transiently expressed in HEK 293 cells. Amino Acids. 17:243–255.[Medline]

Morales, M., N. McCollum, and E. F. Kirkness. 2001. 5-HT3-receptor subunits A and B are co-expressed in neurons of the dorsal root ganglion. J. Comp. Neurol. 438:163–172.[Medline]

Mott, D. D., K. Erreger, T. G. Banke, and S. F. Traynelis. 2001. Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy. J. Physiol. 535:427–443.[Abstract/Free Full Text]

Reeves, D. C., and S. C. R. Lummis. 2002. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel. Mol. Membr. Biol. 19:11–26.[Medline]

Roerig, B., D. A. Nelson, and L. C. Katz. 1997. Fast synaptic signalling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. J. Neurosci. 17:8353–8362.[Abstract/Free Full Text]

Sato, N., M. Sakamori, K. Haga, S. Takehara, and M. Setoguchi. 1992. Antagonistic activity of Y-25130 on 5-HT3 receptors. Jpn. J. Pharmacol. 59:443–448.[Medline]

Shao, X. M., J. L. Yakel, and M. B. Jackson. 1991. Differentiation of NG108–15 cells alters channel conductance and desensitization kinetics of the 5-HT3 receptor. J. Neurophysiol. 65:630–638.[Abstract/Free Full Text]

Sugita, S., K. Z. Shen, and R. A. North. 1992. 5-Hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat lateral amygdala. Neuron. 8:199–203.[Medline]

Sun, Y., R. Olson, M. Horning, N. Armstrong, M. Mayer, and E. Gouaux. 2002. Mechanism of glutamate receptor desensitization. Nature. 417:245–253.[Medline]

van Hooft, J. A., A. P. Kreikamp, and H. P. Vijverberg. 1997. Native 5-HT3 receptors expressed in Xenopus oocytes differ from homopentameric 5-HT3 receptors. J. Neurochem. 69:1318–1321.[Medline]

van Hooft, J. A., and H. P. M. Vijverberg. 1996. Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists. Br. J. Pharmacol. 117:839–846.[Medline]

van Hooft, J. A., and H. P. M. Vijverberg. 2000. 5-HT3 receptors and neurotransmitter release in the CNS: a nerve ending story? Trends Neurosci. 23:605–610.[Medline]

Yakel, J. L. 1996. Desensitization of 5-HT3 receptors expressed in Xenopus oocytes: dependence on voltage and primary structure. Behav. Brain Res. 73:269–272.[Medline]

Yakel, J. L. 1992. 5-HT3 receptors as cation channels. In Central and Peripheral 5-HT3 Receptors. M. Hamon, editor. Academic Press, London. 103–128.

Yakel, J. L., A. Lagrutta, J. P. Adelman, and R. A. North. 1993. Single amino acid substitution affects desensitization of the 5-hydroxytryptamine type 3 receptor expressed in Xenopus oocytes. Proc. Natl. Acad. Sci. USA. 90:5030–5033.[Abstract/Free Full Text]

Yang, J. 1990. Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells. J. Gen. Physiol. 96:1177–1198.[Abstract/Free Full Text]

Yang, J., A. Mathie, and B. Hille. 1992. 5-HT3 receptor channels in dissociated rat superior cervical ganglion neurons. J. Physiol. 448:237–256.[Abstract/Free Full Text]

Zhou, X., and J. J. Galligan. 1999. Synaptic activation and properties of 5-hydroxytryptamine3 receptors in myenteric neurons of guinea pig intestine. J. Pharmacol. Exp. Ther. 290:803–810.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Physiol.Home page
Y. Noam, W. J. Wadman, and J. A. van Hooft
On the voltage-dependent Ca2+ block of serotonin 5-HT3 receptors: a critical role of intracellular phosphates
J. Physiol., August 1, 2008; 586(15): 3629 - 3638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-Q. Hu and R. W. Peoples
The 5-HT3B Subunit Confers Spontaneous Channel Opening and Altered Ligand Properties of the 5-HT3 Receptor
J. Biol. Chem., March 14, 2008; 283(11): 6826 - 6831.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-Q. Hu and R. W. Peoples
Arginine 246 of the Pretransmembrane Domain 1 Region Alters 2,2,2-Trichloroethanol Action in the 5-Hydroxytryptamine3A Receptor
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1011 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Xiong, M. Hosoi, B.-N. Koo, and L. Zhang
Anandamide Inhibition of 5-HT3A Receptors Varies with Receptor Density and Desensitization
Mol. Pharmacol., February 1, 2008; 73(2): 314 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-Q. Hu, H. Sun, R. W. Peoples, R. Hong, and L. Zhang
An Interaction Involving an Arginine Residue in the Cytoplasmic Domain of the 5-HT3A Receptor Contributes to Receptor Desensitization Mechanism
J. Biol. Chem., August 4, 2006; 281(31): 21781 - 21788.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. C. Reeves, M. Jansen, M. Bali, T. Lemster, and M. H. Akabas
A Role for the {beta}1-{beta}2 Loop in the Gating of 5-HT3 Receptors
J. Neurosci., October 12, 2005; 25(41): 9358 - 9366.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)